期刊文献+

胎儿颈项透明层增厚的产前诊断研究进展

Research progress on prenatal diagnosis of thickening of nuchal translucency in fetuses
下载PDF
导出
摘要 颈项透明层(NT)测量是妊娠11-13^(+6)周胎儿超声检查的常规项目,NT异常增厚是胎儿遗传学异常、结构异常及其他病理状况的重要超声标记物之一。既往针对NT增厚胎儿的遗传学检查主要为细胞水平的染色体核型分析技术及分子水平的拷贝数变异检测。近年来,全外显子组测序技术的快速发展将NT增厚的遗传学病因研究深入到基因层面,给NT增厚胎儿的产前诊断带来了新的选择。本文就胎儿NT增厚的产前诊断研究进展予以综述,以期为出生缺陷的产前防控提供参考依据。 The measurement of nuchal translucency(NT)is a routine program in fetal ultrasound examination at 11 to 13^(+6) weeks of gestation,and abnormal NT thickening is one of the important ultrasonic markers for fetal genetic abnormalities,structural abnormalities and other pathological conditions.Previous genetic tests for NT thickening fetuses mainly include chromosome karyotype analysis at cellular level and copy number variation detection at molecular level.In recent years,with the rapid development of whole exome sequencing technology,the genetic etiology of NT thickening has been deeply studied at the gene level,which brings a new choice for prenatal diagnosis of NT thickening fetuses.This article reviewed the research progress of prenatal diagnosis of fetal NT thickening in order to provide reference for prenatal prevention and control of birth defects.
作者 贾玮玮 张庆 王冰 JIA Weiwei;ZHANG Qing;WANG Bing(Department of Gynecology and Obstetrics,the Second Affiliated Hospital of Zhengzhou University,Zhengzhou,Henan,450014)
出处 《实用临床医药杂志》 2023年第11期142-148,共7页 Journal of Clinical Medicine in Practice
基金 2022年度河南省重点研发专项(221111310700)。
关键词 颈项透明层 超声检查 产前诊断 全外显子组测序 遗传学 nuchal translucency ultrasonic examination prenatal diagnosis whole exome sequencing genetics
  • 相关文献

参考文献13

二级参考文献75

  • 1胎儿常见染色体异常与开放性神经管缺陷的产前筛查与诊断技术标准 第2部分:胎儿染色体异常的细胞遗传学产前诊断技术标准[J].中国产前诊断杂志(电子版),2011(4):46-59. 被引量:28
  • 2American College of Medical Genetics. Prenatal interphase fluorescence in situ hybridization (FISH) policy statement[J]. Am J Hum Genet, 1993,53(2):526-527.
  • 3Technical and clinical assessment of fluorescence in situ hybridization: an ACMG/ASHG position statement. I. Technical considerations. Test and Technology Transfer Committee[J]. Genet Med, 2000,2(6):356-361.
  • 4American College of Medical Genetics and Genomics. Standards and guidelines for clinical genetics laboratories, Section E: clincal cytogenetics-2011[EB/OL]. [2016-01-25]. https://www.aemg.net/StaticContent/SGs/Section_E_2011 .pdf.
  • 5Schwartz S. Preparation of Amniocytes for Interphase Fluorescence In Situ Hybridization (FISH)[J]. Curr Protoc Hum Genet, 2015,85:8.9.1-8.9.16. DOI: 10.1002/0471142905. hgO809s85.
  • 6Sparkes R, Johnson JA, Langlois S, et al. New molecular techniques for the prenatal detection of chromosomal aneuploidy[J]. J Obstet Gynaecol Can, 2008,30(7):617-627.
  • 7Sheets KB, Crissman BG, Feist CD, et al. Practice guidelines for communicating a prenatal or postnatal diagnosis of Down syndrome: recommendations of the national society of genetic counselors[J]. J Genet Couns, 2011,20(5):432-441. DOI: 10.1007/s10897-011-9375-8.
  • 8Hong Kong College of Obstetricians and Gynaeeologists.HKCOG Guidelines Number 4 (revised November 2009): Guidelines for amniocentesis and chorionic villus sampling (CVS) [EB/OL]. [2016-01-25]. http://www.hkcog.org.hk/hkcog/ Download/Guidelines_for_Amniocentesis and Chorionic_Vi- llus_Sampling_2009.pdf.
  • 9Nagan N, Faulkner NE, Curtis C, et al. Laboratory guidelines for detection, interpretation, and reporting of maternal cellcontamination in prenatal analyses a report of the association for molecular pathology[J]. J Mol Diagn, 2011, 13(1):7-11. DOI: 10.1016/j.jmoldx.2010.11.013.
  • 10Shaffer LG, McGowan-Jordan J, Schmid M. ISCN 2013: an international system for human cytogenetic nomenclature (2013)[M]. Basel: Karger, 2013:105-120.

共引文献342

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部